Neuroimmunology Antibody Follow-up, Spinal Fluid
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Monitoring patients who have previously tested positive for paraneoplastic autoantibodies utilizing PNEOE / Paraneoplastic Autoantibody Evaluation, Spinal Fluid
Reflex Tests Lists test(s) that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial test(s)
|Test ID||Reporting Name||Available Separately||Always Performed|
|ANN1C||Anti-Neuronal Nuclear Ab, Type 1||No||No|
|ANN2C||Anti-Neuronal Nuclear Ab, Type 2||No||No|
|ANN3C||Anti-Neuronal Nuclear Ab, Type 3||No||No|
|AGN1C||Anti-Glial Nuclear Ab, Type 1||No||No|
|PCA1C||Purkinje Cell Cytoplasmic Ab Type 1||No||No|
|PCA2C||Purkinje Cell Cytoplasmic Ab Type 2||No||No|
|PCTRC||Purkinje Cell Cytoplasmc Ab Type Tr||No||No|
|AMPHC||Amphiphysin Ab, CSF||No||No|
This follow-up evaluation is used to monitor patients who tested positive for 1 or more antibodies in the Neuroimmunology Laboratory within the past 15 months.